- Home
- CMPS vs APPS Comparison
CMPS vs APPS Comparison
Compare CMPS & APPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- APPS
- Stock Information
- Founded
- CMPS 2020
- APPS 2007
- Country
- CMPS United Kingdom
- APPS United States
- Employees
- CMPS N/A
- APPS N/A
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- APPS Multi-Sector Companies
- Sector
- CMPS Health Care
- APPS Miscellaneous
- Exchange
- CMPS Nasdaq
- APPS Nasdaq
- Market Cap
- CMPS 246.5M
- APPS 243.8M
- IPO Year
- CMPS 2020
- APPS N/A
- Fundamental
- Price
- CMPS $3.51
- APPS $3.05
- Analyst Decision
- CMPS Strong Buy
- APPS Hold
- Analyst Count
- CMPS 6
- APPS 4
- Target Price
- CMPS $20.20
- APPS $2.38
- AVG Volume (30 Days)
- CMPS 836.8K
- APPS 3.2M
- Earning Date
- CMPS 05-07-2025
- APPS 05-27-2025
- Dividend Yield
- CMPS N/A
- APPS N/A
- EPS Growth
- CMPS N/A
- APPS N/A
- EPS
- CMPS N/A
- APPS N/A
- Revenue
- CMPS N/A
- APPS $483,577,000.00
- Revenue This Year
- CMPS N/A
- APPS N/A
- Revenue Next Year
- CMPS N/A
- APPS $6.49
- P/E Ratio
- CMPS N/A
- APPS N/A
- Revenue Growth
- CMPS N/A
- APPS N/A
- 52 Week Low
- CMPS $2.49
- APPS $1.18
- 52 Week High
- CMPS $9.63
- APPS $6.86
- Technical
- Relative Strength Index (RSI)
- CMPS 60.07
- APPS 51.06
- Support Level
- CMPS $2.94
- APPS $2.78
- Resistance Level
- CMPS $3.11
- APPS $3.18
- Average True Range (ATR)
- CMPS 0.22
- APPS 0.35
- MACD
- CMPS 0.11
- APPS 0.07
- Stochastic Oscillator
- CMPS 93.57
- APPS 84.11
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About APPS Digital Turbine Inc.
Digital Turbine Inc is an independent mobile growth platform. It offers end-to-end products and solutions to all participants in the mobile application ecosystem, enabling brand discovery and advertising, user acquisition and engagement, and operational efficiency for advertisers. Its operating segments are On Device Solutions and App Growth Platform.